ctrl K

Watchlist Price Alert

Carmell Therapeutics Corp... (CTCX)

NASDAQ: CTCX · Real-Time Price · USD

0.20

0.01 (2.77%)

At close: Mar 07, 2025, 3:55 PM

Carmell Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.91M	128.15K	12.36K
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	156.69M	154.45M
Other Long-Term Assets	n/a	-156.69M	-154.45M
Receivables	204.56K	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	59.02M	28.18K	198.98K
Total Current Assets	62.9M	605.54K	178.7K
Property-Plant & Equipment	1.02M	1.11M	1.35M
Goodwill & Intangibles	24.19K	28.7K	33.22K
Total Long-Term Assets	1.05M	1.14M	1.38M
Total Assets	63.95M	1.75M	1.56M
Account Payables	4.42M	2.14M	871.31K
Deferred Revenue	n/a	1.39M	2.37M
Short-Term Debt	1.29M	2.78M	8.6M
Other Current Liabilities	31.35M	941.14K	4.33M
Total Current Liabilities	38.5M	7.3M	15.8M
Long-Term Debt	n/a	n/a	922.00
Other Long-Term Liabilities	n/a	31.42M	14.37M
Total Long-Term Liabilities	697.72K	32.24M	15.33M
Total Liabilities	39.2M	39.54M	31.13M
Total Debt	2.14M	3.74M	9.69M
Common Stock	2.31K	14.53K	36.92K
Retained Earnings	-58.5M	-42.38M	-32.77M
Comprehensive Income	n/a	-31.42M	n/a
Shareholders Equity	24.75M	-37.79M	-29.58M
Total Investments	n/a	156.69M	154.45M